Michael F. Mahoney - Feb 16, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 16, 2023
Transactions value $
-$1,050,347
Form type
4
Date filed
2/21/2023, 03:19 PM
Previous filing
Feb 16, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +16.3K +0.9% $0.00 1.83M Feb 16, 2023 Direct F1
transaction BSX Common Stock Tax liability -$335K -7.21K -0.39% $46.48 1.82M Feb 16, 2023 Direct
transaction BSX Common Stock Options Exercise $0 +18.3K +1.01% $0.00 1.84M Feb 17, 2023 Direct F1
transaction BSX Common Stock Tax liability -$378K -8.13K -0.44% $46.54 1.83M Feb 17, 2023 Direct
transaction BSX Common Stock Options Exercise $0 +16.3K +0.89% $0.00 1.85M Feb 18, 2023 Direct F2
transaction BSX Common Stock Tax liability -$337K -7.23K -0.39% $46.54 1.84M Feb 18, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -16.3K -25% $0.00 48.8K Feb 16, 2023 Common Stock 16.3K Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -18.3K -33.33% $0.00 36.7K Feb 17, 2023 Common Stock 18.3K Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -16.3K -50% $0.00 16.3K Feb 18, 2023 Common Stock 16.3K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.